Correlation Between Catalyst Pharmaceuticals and Fortress Transp

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Fortress Transp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Fortress Transp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Fortress Transp Infra, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Fortress Transp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Fortress Transp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Fortress Transp.

Diversification Opportunities for Catalyst Pharmaceuticals and Fortress Transp

0.43

Correlation Coefficient

Catalyst Pharmaceuticals  Fortress Transp

Very weak diversification

The 3 months correlation between Catalyst and Fortress is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Fortress Transp Infra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Transp Infra and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Fortress Transp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Transp Infra has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Fortress Transp go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Fortress Transp

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.58 times more return on investment than Fortress Transp. However, Catalyst Pharmaceuticals is 1.73 times less risky than Fortress Transp. It trades about 0.01 of its potential returns per unit of risk. Fortress Transp Infra is currently generating about -0.41 per unit of risk. If you would invest  2,193  in Catalyst Pharmaceuticals on September 27, 2024 and sell it today you would lose (2.00) from holding Catalyst Pharmaceuticals or give up 0.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Fortress Transp Infra

Catalyst Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Fortress Transp Infra

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Transp Infra are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Fortress Transp is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Catalyst Pharmaceuticals and Fortress Transp

The main advantage of trading using opposite Catalyst Pharmaceuticals and Fortress Transp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Fortress Transp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Transp will offset losses from the drop in Fortress Transp's long position.

The idea behind Catalyst Pharmaceuticals and Fortress Transp Infra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.